[{"NetIncomeLoss_2_Q2_USD":810112000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-34526000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-68140000.0,"Depreciation_2_Q2_USD":154682000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-314232000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-69248000.0,"OtherComprehensiveIncomeOtherNetOfTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeOtherNetOfTax_2_Q2_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":3102000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":1532171000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-6700000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":2957000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RepaymentsOfLongTermDebt_2_Q2_USD":523717000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":99200000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.44,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.88,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":441300000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-1262000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":0.0,"DividendsCommonStockCash_1_Q2_USD":91262000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":200000.0,"TreasuryStockShares_0_Q2_shares":84633085.0,"CostOfGoodsAndServicesSold_1_Q2_USD":47620790000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":98685116000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":730081000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":1465149000.0,"RestructuringCharges_1_Q2_USD":78156000.0,"DividendsCommonStockCash_2_Q2_USD":182365000.0,"RestructuringCharges_2_Q2_USD":148537000.0,"LongTermDebtCurrent_0_Q2_USD":7860000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q2_USD":78156000.0,"RestructuringSettlementAndImpairmentProvisions_2_Q2_USD":148537000.0,"LongTermDebt_0_Q2_USD":6190997000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":2399000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":2259000.0,"AssetsCurrent_0_Q2_USD":35469149000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-36872000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":2600000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":6856000.0,"SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit_0_Q2_USD":16700000.0,"Revenues_1_Q2_USD":49154171000.0,"Revenues_2_Q2_USD":101670727000.0,"CommonStockValue_0_Q2_USD":2900000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":132506000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":281681000.0,"AccountsReceivableNetCurrent_0_Q2_USD":14134326000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-145861000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":21400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":207315000.0,"AdjustmentForAmortization_2_Q2_USD":54683000.0,"MinorityInterest_0_Q2_USD":178974000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":100700000.0,"EarningsPerShareBasic_1_Q2_USD":2.12,"EarningsPerShareBasic_2_Q2_USD":3.96,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":733395000.0,"ContractWithCustomerAssetGrossCurrent_0_Q2_USD":1217032000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":207063000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":31259000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":39083000.0,"TreasuryStockValueAcquiredCostMethod_1_Q2_USD":20196000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":5278379000.0,"OtherAssetsNoncurrent_0_Q2_USD":1199888000.0,"InventoryLIFOReservePeriodCharge_2_Q2_USD":-46645000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":25527000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":51135000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-292555000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":436486000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":849694000.0,"IncreaseDecreaseInInventories_2_Q2_USD":314294000.0,"DepreciationNonproduction_1_Q2_USD":75270000.0,"DepreciationNonproduction_2_Q2_USD":149215000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":2585538000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1908516000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.234,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.257,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":2572480000.0,"TreasuryStockValueAcquiredCostMethod_2_Q2_USD":82150000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":429786000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":130326000.0,"TreasuryStockValue_0_Q2_USD":6618763000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":204916000.0,"CommonStockDividendsPerShareCashPaid_1_Q2_USD":0.44,"CommonStockDividendsPerShareCashPaid_2_Q2_USD":0.88,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":449150000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-4219000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":39939000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":18793000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":204804000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":67110000.0,"Goodwill_0_Q2_USD":6709821000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":97600000.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":162620000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":96700000.0,"EarningsPerShareDiluted_1_Q2_USD":2.1,"EarningsPerShareDiluted_2_Q2_USD":3.91,"CommonStockSharesOutstanding_0_Q2_shares":205326154.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":23530000.0,"AssetImpairmentCharges_1_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":32996446000.0,"NonoperatingIncomeExpense_1_Q2_USD":-23310000.0,"NetIncomeLoss_1_Q2_USD":435267000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1482753000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-3410000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":768551000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":-102782000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":182365000.0,"GrossProfit_1_Q2_USD":1533381000.0,"AccountsPayableCurrent_0_Q2_USD":31420390000.0,"GrossProfit_2_Q2_USD":2985611000.0,"LongTermDebtNoncurrent_0_Q2_USD":6147112000.0,"SeveranceCosts1_1_Q2_USD":0.0,"SeveranceCosts1_2_Q2_USD":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":130326000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":190644000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":6641180000.0,"NonoperatingIncomeExpense_2_Q2_USD":-9042000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":1839085000.0,"AssetImpairmentCharges_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":193770000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":2043434000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-18639000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AccruedIncomeTaxesNoncurrent_0_Q2_USD":273031000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":302554000.0,"LegalFees_1_Q2_USD":41988000.0,"LegalFees_2_Q2_USD":74050000.0,"ShareBasedCompensation_2_Q2_USD":67110000.0,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"StockholdersEquityOther_1_Q2_USD":184000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-4219000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":39939000.0,"UnrecognizedTaxBenefitsPeriodIncreaseDecrease_2_Q2_USD":7500000.0,"Assets_0_Q2_USD":47003250000.0,"CommonStockSharesIssued_0_Q2_shares":289959239.0,"GainLossRelatedToLitigationSettlement_2_Q2_USD":0.0,"GainLossRelatedToLitigationSettlement_1_Q2_USD":0.0,"StockholdersEquityOther_2_Q2_USD":1094000.0,"OperatingIncomeLoss_1_Q2_USD":624347000.0,"OperatingIncomeLoss_2_Q2_USD":1171575000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":1094393000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":1124976000.0,"DebtCurrent_0_Q2_USD":43885000.0,"LitigationReserveNoncurrent_0_Q2_USD":6212718000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":151612000.0,"StockholdersEquity_0_Q2_USD":-281756000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":708174000.0,"ProfitLoss_2_Q2_USD":812712000.0,"ProfitLoss_1_Q2_USD":434005000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":102000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":47003250000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":141601000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-157136000.0,"IncomeTaxesReceivable_0_Q2_USD":331291000.0,"InventoryNet_0_Q2_USD":12954676000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":-21791000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":82150000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":566511000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":72110000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":852651000.0,"Ticker":"ABC","CIK":"1140859","name":"AMERISOURCEBERGEN CORP","OfficialName":"AmerisourceBergen Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"34058030313.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20210505"}]